BioSpace News Archive

Y-mAbs Therapeutics, Inc. announced the appointment of Norman LaFrance, M.D. as Chief Development Officer.

Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the company will host a fireside chat at the Goldman Sachs 45th Annual Global Healthcare Conference on Wednesday, June 12, 2024, at 4:00 p.m. ET.

LSL PHARMA GROUP INC. announced the launch of a non-brokered private placement financing of Units of a maximum of $3.0 million and that it is conducting discussions with its creditors to settle debts in Units for an aggregate amount of up to $1.5 million.

Altimmune, Inc., a clinical-stage biopharmaceutical company, presented new data on the potential anti-inflammatory and anti-fibrotic properties of pemvidutide in Metabolic Dysfunction-Associated Steatohepatitis at the EASL International Liver Congress™ 2024 in Milan, Italy.

CytoSorbents Corporation announces that it will host its 2024 Virtual Annual Stockholders Meeting tomorrow, June 6, 2024 at 10 AM EDT.

ACELYRIN, INC. (Nasdaq: SLRN), a late-stage clinical biopharma company focused on accelerating the development and delivery of transformative medicines in immunology, today announced that positive results from the company’s global Phase 2b/3 clinical trial of izokibep in psoriatic arthritis (PsA) will be shared as a late breaking oral presentation at the 2024 European Alliance of Associations for Rheumatology Congress taking place June 12-15 in Vienna, Austria.

Eko Health, a pioneer in applying artificial intelligence for early detection of heart and lung diseases, announced it has raised $41 million in Series D financing.

Syndax Pharmaceuticals today announced that Michael A. Metzger, Chief Executive Officer, will participate in a fireside chat at the Goldman Sachs 45th Annual Global Healthcare Conference on Wednesday, June 12, 2024.

Danaher Corporation today announced the creation of the new role of Chief Data & Artificial Intelligence Officer.

Passage Bio, Inc. today announced that William Chou, M.D., president and chief executive officer, will present at the Goldman Sachs 45th Annual Global Healthcare Conference on Wednesday, June 12, 2024 at 4:00 p.m. ET.